Isseki Maeda

2.8k total citations
96 papers, 1.5k citations indexed

About

Isseki Maeda is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Clinical Psychology. According to data from OpenAlex, Isseki Maeda has authored 96 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Public Health, Environmental and Occupational Health, 30 papers in Oncology and 21 papers in Clinical Psychology. Recurrent topics in Isseki Maeda's work include Palliative Care and End-of-Life Issues (50 papers), Cancer survivorship and care (21 papers) and Intensive Care Unit Cognitive Disorders (16 papers). Isseki Maeda is often cited by papers focused on Palliative Care and End-of-Life Issues (50 papers), Cancer survivorship and care (21 papers) and Intensive Care Unit Cognitive Disorders (16 papers). Isseki Maeda collaborates with scholars based in Japan, United States and South Korea. Isseki Maeda's co-authors include Tatsuya Morita, Mitsunori Miyashita, Satoru Tsuneto, Masanori Mori, Yoshio Konishi, Takashi Yamaguchi, Kyoko Satō, Takuhiro Yamaguchi, Tomoshige Hayashi and Takashi Morikawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Isseki Maeda

88 papers receiving 1.5k citations

Peers

Isseki Maeda
Jeff Borenstein United States
Peter J. Edmonds United States
In Cheol Hwang South Korea
A Avenell United Kingdom
Sang‐Yeon Suh South Korea
Ki Young Son South Korea
Ching-Yun Wang United States
Jarcy Zee United States
Jeff Borenstein United States
Isseki Maeda
Citations per year, relative to Isseki Maeda Isseki Maeda (= 1×) peers Jeff Borenstein

Countries citing papers authored by Isseki Maeda

Since Specialization
Citations

This map shows the geographic impact of Isseki Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isseki Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isseki Maeda more than expected).

Fields of papers citing papers by Isseki Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isseki Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isseki Maeda. The network helps show where Isseki Maeda may publish in the future.

Co-authorship network of co-authors of Isseki Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Isseki Maeda. A scholar is included among the top collaborators of Isseki Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isseki Maeda. Isseki Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Yoichi, Isseki Maeda, Tomofumi Miura, et al.. (2024). Resilience and coping styles in family caregivers of terminally ill patients: A cross-sectional survey. Palliative & Supportive Care. 23. e12–e12.
2.
3.
Hasegawa, Takaaki, Masanori Mori, Takashi Yamaguchi, et al.. (2024). Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study. Journal of Palliative Medicine. 28(4). 437–445.
4.
Imai, Kengo, Tatsuya Morita, Masanori Mori, et al.. (2023). Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. Journal of Pain and Symptom Management. 65(6). 479–489. 2 indexed citations
5.
Ikari, Tomoo, Yusuke Hiratsuka, Shao‐Yi Cheng, et al.. (2022). Factors associated with good death of patients with advanced cancer: a prospective study in Japan. Supportive Care in Cancer. 30(11). 9577–9586. 3 indexed citations
6.
Aoyama, Maho, Yusuke Hiratsuka, Masanori Mori, et al.. (2022). Symptoms, performance status and phase of illness in advanced cancer: multicentre cross-sectional study of palliative care unit admissions. BMJ Supportive & Palliative Care. 13(e3). e1174–e1180. 1 indexed citations
7.
Mori, Masanori, Takashi Kawaguchi, Kengo Imai, et al.. (2021). Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study. Journal of Pain and Symptom Management. 62(5). 936–948. 8 indexed citations
9.
Hiratsuka, Yusuke, Sang‐Yeon Suh, Isseki Maeda, et al.. (2020). Factors influencing spiritual well-being in terminally ill cancer inpatients in Japan. Supportive Care in Cancer. 29(5). 2795–2802. 9 indexed citations
10.
Niki, Kazuyuki, Yoshiaki Okamoto, Isseki Maeda, et al.. (2019). A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. Journal of Palliative Medicine. 22(6). 702–707. 101 indexed citations
11.
Ishiki, Hiroto, et al.. (2019). A survey of practice in management of malignancy-related ascites in Japan. PLoS ONE. 14(8). e0220869–e0220869. 6 indexed citations
12.
Maeda, Isseki, et al.. (2019). Risk Factors for Polypharmacy in Elderly Patients With Cancer Pain. American Journal of Hospice and Palliative Medicine®. 36(7). 598–602. 10 indexed citations
13.
Amano, Koji, Isseki Maeda, Hiroto Ishiki, et al.. (2016). A Feasibility Study to Investigate the Effect of Nutritional Support for Advanced Cancer Patients in an Inpatient Hospice in Japan. 2(2). 37–45. 6 indexed citations
14.
Jho, Hyun Jung, Sang‐Yeon Suh, Seok‐Joon Yoon, et al.. (2016). Prospective Validation of the Objective Prognostic Score for Advanced Cancer Patients in Diverse Palliative Settings. Journal of Pain and Symptom Management. 52(3). 420–427. 13 indexed citations
15.
Maeda, Isseki, Mitsunori Miyashita, Akemi Yamagishi, et al.. (2016). Changes in Relatives' Perspectives on Quality of Death, Quality of Care, Pain Relief, and Caregiving Burden Before and After a Region-Based Palliative Care Intervention. Journal of Pain and Symptom Management. 52(5). 637–645. 16 indexed citations
16.
Maeda, Isseki, Satoru Tsuneto, Mitsunori Miyashita, et al.. (2014). Progressive Development and Enhancement of Palliative Care Services in Japan: Nationwide Surveys of Designated Cancer Care Hospitals for Three Consecutive Years. Journal of Pain and Symptom Management. 48(3). 364–373. 14 indexed citations
17.
Maeda, Isseki, Tomoshige Hayashi, Kyoko Satō, et al.. (2012). Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy. Nephrology Dialysis Transplantation. 27(7). 2806–2813. 44 indexed citations
18.
Satō, Kyoko, Tomoshige Hayashi, Nobuko Harita, et al.. (2011). Elevated White Blood Cell Count Worsens Proteinuria but Not Estimated Glomerular Filtration Rate: The Kansai Healthcare Study. American Journal of Nephrology. 34(4). 324–329. 3 indexed citations
19.
Koh, Hideo, Tomoshige Hayashi, Kyoko Satō, et al.. (2011). Blood pressure components and risk for chronic kidney disease in middle-aged Japanese men: The Kansai Healthcare Study. Hypertension Research. 34(4). 536–541. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026